TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Metabolic Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Metabolic Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Metabolic Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Metabolic Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Metabolic Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Metabolic Drugs industry

EP3570885Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 18, 2025JG OPPOSITIONS
EP3854403Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
EP3882275Anti-Pd-1 And Anti-Vegfa Bifunctional Antibody, Pharmaceutical Composition Thereof And Use ThereofAKESO BIOPHARMAJun 18, 2025STRAWMAN
EP4241849Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 18, 2025ABEL & IMRAY
EP3570885Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 17, 2025CAMULON
EP4241849Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 17, 2025LANYON OPPOSITIONS
EP3570885Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 16, 2025BOULT WADE TENNANT
EP3897582Process Of Spray Drying Of Glp-1 PeptideNOVO NORDISKJun 11, 2025GENERICS UK
EP4069254Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICALJun 11, 2025BOTTI & FERRARI
EP4129270Modified Release Orally Administered Amino Acid FormulationsAPR APPLIED PHARMA RESEARCHJun 10, 2025MAIWALD

To stay ahead in the competitive Metabolic Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Metabolic Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2959894Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
EP2962690Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
EP2493466Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI MATURE13
EP3078667Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
EP3725778Aug 18, 2021Formulations Of EnzalutamideASTELLAS PHARMA11
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
EP2981255Sep 14, 2022Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM10
EP3342411Aug 21, 2019Rapamycin Derivative For Treating Pancreas CancerNOVARTIS10